Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Medicare Shakeup: Policy Changes Rattle Big Insurers

by Team Lumida
May 17, 2024
in Macro, News
Reading Time: 4 mins read
A A
0
emergency signage

Photo by Pixabay on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Biden administration’s policy changes reduce Medicare Advantage profitability.
  2. Insurers like CVS and Humana face rising costs and declining profits.
  3. Market and regulatory challenges could reshape the future of Medicare Advantage.

What Happened?

The Medicare Advantage landscape has dramatically shifted. Medicare Advantage, a program where the government pays insurers to manage senior care, has been a major profit driver for companies like UnitedHealth Group and Humana. However, the Biden administration’s recent policy changes have altered the payment structures, causing a significant dip in profitability.

CVS Health’s Aetna unit reported a $900 million surge in unexpected medical costs, leading to its largest one-day share drop in nearly 15 years. As a result, CVS shares have plunged 26% this year, equating to a market cap of just over $70 billion—the same amount it paid for Aetna in 2018. Humana and UnitedHealth have also seen their shares drop by over 20% and 16%, respectively.

Why It Matters?

These changes have rattled investors and corporate boards, signaling a shift from growth to profitability in the Medicare Advantage sector. With the government tightening its purse strings and implementing stricter policies, insurers must adapt quickly. CVS plans to exit some markets and cut back on benefits to improve margins.

Thomas Cowhey, CVS Chief Financial Officer, stated, “The goal for next year is margin over membership.” This shift could open opportunities for companies with better profit margins like UnitedHealth to gain market share. However, the regulatory environment remains a tougher challenge, with tighter payment rates and changes in coding patient risk.

What’s Next?

Insurers are now focusing on mitigating rising costs and adapting to new regulations. Expect strategic exits from less profitable markets and reductions in member benefits. Analysts predict Humana, despite expected lower earnings this year, will rebound to $26 per share by 2026. The industry’s lobbying efforts will intensify to influence public and policymaker opinions.

Wendell Potter, a former Cigna executive, highlighted, “Companies will be investing heavily through campaign donations and lobbying.” A potential Donald Trump win in the upcoming presidential elections could favor privatization and benefit Medicare Advantage. Regardless, the sector remains profitable but without the extraordinary gains seen in recent years.

Source: WSJ
Previous Post

Why Bitcoin’s Correlation with Nasdaq Is Skyrocketing

Next Post

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Recommended For You

JPMorgan Names Bregje de Best as Its Next CFO, With Jeremy Barnum Moving to Vice Chairman and Staying Through Early 2028

by Team Lumida
2 hours ago
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

JPMorgan plans to name Bregje de Best CFO after first-quarter results, with Jeremy Barnum becoming vice chairman through early 2028.

Read more

The 10-Year Treasury Yield Is Nearing Its Longest Stretch Above 5% Since 2007, With 27 Closes Above the Level in 2026 and a December Hike 95% Priced

by Team Lumida
2 hours ago
KKR Lifts Its 10-Year Treasury Call to 5.1% and Pushes the Fed Hold Out to Early 2029

The 10-year yield, near 5.13%, is nearing its longest run above 5% since 2007, with 27 closes above that level so far in 2026.

Read more

Dow Falls 760 Points as Chip Stocks Slide Into Nvidia Earnings, With Micron Down 6% and Nvidia on Pace for Its Worst Month Since April 2022

by Team Lumida
2 hours ago
BlackRock’s Larry Fink on Economic Growth and Market Misconceptions

The Dow fell 760 points as chipmakers slid ahead of Nvidia earnings, with Micron down about 6% and Nvidia off 26% this month.

Read more

‘Big Short’ Investor Steve Eisman Says AI Neoclouds Are in ‘Big Trouble’ as Nvidia’s ‘Virtual Vertical Holding Company’ Unwinds

by Team Lumida
2 hours ago

Steve Eisman said AI neocloud stocks face the biggest fallout from the Nvidia scandal and favored hyperscalers if data center building slows.

Read more

Jensen Huang Will Testify Before Three House Committees on Dec. 1, as Nvidia Creates a Board Committee to Oversee Export Controls and National Security

by Team Lumida
2 hours ago

Former Nvidia CEO Jensen Huang will appear before three House panels Dec. 1 as Nvidia formed a board committee on export controls.

Read more

Options Price a 7% Nvidia Earnings Move, the Biggest Since February 2025, as the Stock Sits 35% Below Its October High and Morgan Stanley Calls It the Most Under-Owned Large-Cap Tech Name

by Team Lumida
2 hours ago

Options traders priced a 7% Nvidia earnings move, the biggest since early 2025, with shares down 35% from their October high and widely under-owned.

Read more

Nike Reaffirms Fiscal 2027 Guidance and Targets $3.00-$3.50 EPS and 12%-14% Margins by 2031 at Its First Investor Day in Nine Years

by Team Lumida
2 hours ago

Nike reaffirmed its fiscal 2027 outlook and set 2031 targets of $3.00 to $3.50 adjusted EPS and 12% to 14% operating margins at its investor day.

Read more

Disney Beats With $1.77 Adjusted EPS on $25.95 Billion Revenue, Targets $3 Billion of Savings by 2029 and Lifts Its Dividend 33% to $2

by Team Lumida
2 hours ago

Disney beat fiscal Q4 estimates, targeted $3 billion in cost savings by fiscal 2029 and raised its annual dividend 33% to $2 a share.

Read more

Home Depot Names CFO Richard McPhail CEO as Ted Decker Steps Down, While Q3 Comps Rise 2.2% but a Soft Holiday Outlook Sends Shares Lower

by Team Lumida
2 hours ago

Home Depot named CFO Richard McPhail CEO and beat Q3 estimates, but a cautious full-year outlook implied fourth-quarter EPS below consensus.

Read more

Anthropic Is Likely to Price Its IPO Above the $70-$78 Range as Books Close, With Nasdaq Trading Under ‘ANT’ Set for Nov. 19

by Team Lumida
2 hours ago

Anthropic is likely to price its IPO above the $70 to $78 range, sources told CNBC, ahead of its Nasdaq debut under the ticker ANT on Nov. 19.

Read more
Next Post
woman with face mask holding an alcohol bottle

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

stock, trading, monitor

Debt Squeeze: Higher Rates, Tighter Budgets, Global Impact

May 31, 2024
Chinese Stock Surge: A Hedge Fund Headache?

China’s Renminbi Hits 16-Month Low Amid Trump Tariff Fears and US Economic Strength

January 8, 2025
Nvidia Defies US Controls: $12 Billion AI Chip Sales in China

Petition to Reinstate Jensen Huang Tops 160,000 Signatures as Altimeter and Atreides Urge Nvidia’s Board to Keep His Return on the Table

November 16, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018